PL1802573T3 - Proces syntezy 4-(3-metanosulfonylofenylo)-1-N-propylopiperydyny - Google Patents
Proces syntezy 4-(3-metanosulfonylofenylo)-1-N-propylopiperydynyInfo
- Publication number
- PL1802573T3 PL1802573T3 PL05793645T PL05793645T PL1802573T3 PL 1802573 T3 PL1802573 T3 PL 1802573T3 PL 05793645 T PL05793645 T PL 05793645T PL 05793645 T PL05793645 T PL 05793645T PL 1802573 T3 PL1802573 T3 PL 1802573T3
- Authority
- PL
- Poland
- Prior art keywords
- methanesulfonylphenyl
- piperidine
- propyl
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61819604P | 2004-10-13 | 2004-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1802573T3 true PL1802573T3 (pl) | 2017-03-31 |
Family
ID=35478927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05793645T PL1802573T3 (pl) | 2004-10-13 | 2005-10-13 | Proces syntezy 4-(3-metanosulfonylofenylo)-1-N-propylopiperydyny |
Country Status (15)
Country | Link |
---|---|
US (1) | US7923459B2 (pl) |
EP (1) | EP1802573B1 (pl) |
JP (1) | JP4891908B2 (pl) |
KR (1) | KR101319235B1 (pl) |
CN (1) | CN101056854B (pl) |
AU (1) | AU2005293754B2 (pl) |
CA (1) | CA2584831C (pl) |
DK (1) | DK1802573T3 (pl) |
ES (1) | ES2659577T3 (pl) |
HK (1) | HK1105195A1 (pl) |
HU (1) | HUE029790T2 (pl) |
MX (1) | MX2007004215A (pl) |
NZ (1) | NZ555094A (pl) |
PL (1) | PL1802573T3 (pl) |
WO (1) | WO2006040155A1 (pl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
DE602005021641D1 (de) | 2004-06-08 | 2010-07-15 | Nsab, Filial Af Neurosearch Sweden Ab | Neue disubstituierte phenylpiperidine und piperazine als modulatoren der dopamin-neurotransmission |
SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
WO2006040156A1 (en) * | 2004-10-13 | 2006-04-20 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines |
WO2006040155A1 (en) | 2004-10-13 | 2006-04-20 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
PT2146961E (pt) * | 2007-04-12 | 2014-04-30 | Ivax Int Gmbh | Derivados de n-óxido e/ou di-n-óxido de estabilizadores / moduladores dos recetores da dopamina exibindo perfis de efeitos secundários cardiovasculares melhorados |
WO2011107583A1 (en) | 2010-03-04 | 2011-09-09 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders |
CA2810092A1 (en) | 2010-09-03 | 2012-03-08 | IVAX International GmbH | Deuterated analogs of pridopidine useful as dopaminergic stabilizers |
EA023462B1 (ru) | 2011-09-07 | 2016-06-30 | Тева Фармасьютикалз Интернэшнл Гмбх | Полиморфная форма гидрохлорида придопидина |
US9012476B2 (en) * | 2011-12-08 | 2015-04-21 | IVAX International GmbH | Hydrobromide salt of pridopidine |
CA2869145A1 (en) | 2012-04-04 | 2013-10-10 | IVAX International GmbH | Pharmaceutical compositions for combination therapy |
US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
KR102316933B1 (ko) | 2013-06-21 | 2021-10-26 | 프리레니아 뉴로테라퓨틱스 엘티디. | 헌팅턴병 치료를 위한 프리도피딘의 용도 |
US20150202302A1 (en) | 2014-01-22 | 2015-07-23 | IVAX International GmbH | Modified release formulations of pridopidine |
TW201613859A (en) | 2014-06-30 | 2016-04-16 | Teva Pharma | Analogs of PRIDOPIDINE, their preparation and use |
WO2016106142A1 (en) * | 2014-12-22 | 2016-06-30 | Teva Pharmaceuticals International Gmbh | L-tartrate salt of pridopidine |
HUE060353T2 (hu) | 2015-02-25 | 2023-02-28 | Prilenia Neurotherapeutics Ltd | Pridopidin alkalmazása memória javítására |
US11471449B2 (en) | 2015-02-25 | 2022-10-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
AR105434A1 (es) * | 2015-07-22 | 2017-10-04 | Teva Pharmaceuticals Int Gmbh | Proceso para preparar pridopidina |
US11738012B2 (en) | 2016-02-24 | 2023-08-29 | Prilenia Neurotherapeutics Ltd. | Treatment of neurodegenerative eye disease using pridopidine |
EP3504187A4 (en) | 2016-08-24 | 2020-05-06 | Prilenia Neurotherapeutics Ltd. | USE OF PRIDOPIDINE FOR THE TREATMENT OF FUNCTIONAL DECLINE |
MX2019002190A (es) | 2016-08-24 | 2019-09-11 | Prilenia Therapeutics Dev Ltd | Uso de pridopidina para tratar distonías. |
CA3036984C (en) | 2016-09-16 | 2023-07-18 | Prilenia Therapeutics Development Ltd. | Use of pridopidine for treating rett syndrome |
CN110505902B (zh) | 2017-01-20 | 2022-11-11 | 普瑞尼亚神经治疗有限公司 | 普利多匹定用于治疗脆性x综合征的应用 |
EP3357909A1 (en) | 2017-02-02 | 2018-08-08 | Sandoz AG | Crystalline 4-[3-(methylsulfonyl)phenyl]-1-propyl-piperidine |
EP3668509B1 (en) | 2017-08-14 | 2022-11-16 | Prilenia Neurotherapeutics Ltd. | Method of treating amyotrophic lateral sclerosis with pridopidine |
CA3073568A1 (en) | 2017-08-30 | 2019-03-07 | Prilenia Neurotherapeutics Ltd. | High concentration dosage forms of pridopidine |
CN111343982A (zh) | 2017-09-08 | 2020-06-26 | 普瑞尼亚神经治疗有限公司 | 用于治疗药物诱发的异动症的普利多匹定 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB850662A (en) | 1956-10-22 | 1960-10-05 | Parke Davis & Co | Substituted piperazines and processes for their production |
BE662455A (pl) * | 1964-04-14 | |||
FR1459013A (fr) | 1964-08-05 | 1966-04-29 | Allen & Hanburys Ltd | Procédé de préparation de dérivés de la 4-phényl-pipéridine |
GB1060160A (en) | 1964-08-05 | 1967-03-01 | Allen & Hanburys Ltd | 4-phenylpiperidine derivatives |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US4048314A (en) * | 1974-12-17 | 1977-09-13 | Delmar Chemicals Limited | Morpholino containing 4-arylpiperidine derivatives |
GB1560271A (en) | 1977-01-14 | 1980-02-06 | Joullie International Sa | Therapeutically useful m-trifluoromethylphenylpiperazine derivatives |
US4202898A (en) * | 1978-06-05 | 1980-05-13 | Synthelabo | Method of treating anxiety and depression |
FR2459797A2 (fr) | 1978-08-01 | 1981-01-16 | Synthelabo | Derives de phenyl-1 piperazine et leur application en therapeutique |
US4333942A (en) * | 1979-08-03 | 1982-06-08 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Anti-depressant and analgesic 4-phenoxypiperidines |
US4518712A (en) | 1980-06-30 | 1985-05-21 | Taiho Pharmaceutical Company Limited | Piperazine derivative and analgesic composition containing the same |
GB2083476B (en) | 1980-09-12 | 1984-02-08 | Wyeth John & Brother Ltd | Heterocyclic compounds |
FR2501506A1 (fr) | 1981-03-11 | 1982-09-17 | Sanofi Sa | Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine |
US4415736A (en) * | 1981-12-28 | 1983-11-15 | E. I. Du Pont De Nemours & Co. | Certain tetrahydropyridine intermediates |
US4485109A (en) * | 1982-05-07 | 1984-11-27 | E. I. Du Pont De Nemours And Company | 4-Aryl-4-piperidinecarbinols |
EP0094159B1 (en) | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives, their production and use |
US4504660A (en) * | 1982-07-06 | 1985-03-12 | American Home Products Corporation | Process for the production of 2,6-diaminobenzonitrile derivatives |
HU198454B (en) | 1987-12-14 | 1989-10-30 | Richter Gedeon Vegyeszet | Process for production of new derivatives of tetrahydrospiridin and medical compositions containing these compounds |
FR2639226B1 (fr) | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
EP0507863A4 (en) | 1989-12-28 | 1993-07-07 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
ES2157204T3 (es) * | 1991-04-17 | 2001-08-16 | Upjohn Co | Derivados de (s)-3-fenilpiperidina sustituidos, su preparacion y uso como antagonistas de autorreceptores de dopamina. |
EP0591426A4 (en) | 1991-06-27 | 1996-08-21 | Univ Virginia Commonwealth | Sigma receptor ligands and the use thereof |
NZ240863A (en) | 1991-09-11 | 1995-04-27 | Mcneilab Inc | Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof |
ATE204262T1 (de) | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | Benzanilidderivate als 5-ht1d-antagonisten |
GB9119932D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
GB9119920D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
US5502050A (en) * | 1993-11-29 | 1996-03-26 | Cornell Research Foundation, Inc. | Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
CA2144669A1 (en) | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
EP0867183B1 (en) * | 1996-07-22 | 2004-10-06 | Daiichi Suntory Pharma Co., Ltd. | Arylpiperidinol and arylpiperidine derivatives and drugs containing the same |
US5892041A (en) * | 1996-08-12 | 1999-04-06 | Neurogen Corporation | Fused indolecarboxamides: dopamine receptor subtype specific ligands |
DE19637237A1 (de) | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
US6232326B1 (en) | 1998-07-14 | 2001-05-15 | Jodi A. Nelson | Treatment for schizophrenia and other dopamine system dysfunctions |
WO2000078728A1 (en) | 1999-06-22 | 2000-12-28 | Neurosearch A/S | Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
SE9904724D0 (sv) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
AU2001280599A1 (en) | 2000-07-15 | 2002-01-30 | Smith Kline Beecham Corporation | Compounds and methods |
EP1368340B1 (en) | 2001-01-23 | 2005-08-10 | Eli Lilly And Company | Piperazine derivatives as melanocortin receptor agonists |
US20050004164A1 (en) | 2003-04-30 | 2005-01-06 | Caggiano Thomas J. | 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
NZ552409A (en) | 2004-06-08 | 2010-04-30 | Nsab Af Neurosearch Sweden Ab | New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
AU2005292134B2 (en) | 2004-10-01 | 2010-12-23 | Merck Sharp & Dohme Corp. | Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
WO2006040156A1 (en) | 2004-10-13 | 2006-04-20 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines |
WO2006040155A1 (en) | 2004-10-13 | 2006-04-20 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
SE529246C2 (sv) | 2005-10-13 | 2007-06-12 | Neurosearch Sweden Ab | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission |
EP1963268B1 (en) | 2005-12-07 | 2010-12-01 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
-
2005
- 2005-10-13 WO PCT/EP2005/011020 patent/WO2006040155A1/en active Application Filing
- 2005-10-13 PL PL05793645T patent/PL1802573T3/pl unknown
- 2005-10-13 JP JP2007536091A patent/JP4891908B2/ja not_active Expired - Fee Related
- 2005-10-13 KR KR1020077010900A patent/KR101319235B1/ko not_active IP Right Cessation
- 2005-10-13 MX MX2007004215A patent/MX2007004215A/es active IP Right Grant
- 2005-10-13 CA CA2584831A patent/CA2584831C/en active Active
- 2005-10-13 NZ NZ555094A patent/NZ555094A/en unknown
- 2005-10-13 DK DK05793645.2T patent/DK1802573T3/en active
- 2005-10-13 CN CN2005800385910A patent/CN101056854B/zh not_active Expired - Fee Related
- 2005-10-13 EP EP05793645.2A patent/EP1802573B1/en active Active
- 2005-10-13 HU HUE05793645A patent/HUE029790T2/hu unknown
- 2005-10-13 ES ES05793645.2T patent/ES2659577T3/es active Active
- 2005-10-13 AU AU2005293754A patent/AU2005293754B2/en not_active Ceased
-
2007
- 2007-04-10 US US11/733,512 patent/US7923459B2/en active Active
- 2007-09-27 HK HK07110459.6A patent/HK1105195A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008515951A (ja) | 2008-05-15 |
EP1802573A1 (en) | 2007-07-04 |
AU2005293754A1 (en) | 2006-04-20 |
MX2007004215A (es) | 2007-12-12 |
US20070238879A1 (en) | 2007-10-11 |
AU2005293754B2 (en) | 2011-07-21 |
CA2584831C (en) | 2013-09-17 |
CN101056854A (zh) | 2007-10-17 |
KR20070065911A (ko) | 2007-06-25 |
EP1802573B1 (en) | 2016-09-28 |
ES2659577T3 (es) | 2018-03-16 |
HUE029790T2 (hu) | 2017-04-28 |
JP4891908B2 (ja) | 2012-03-07 |
NZ555094A (en) | 2009-07-31 |
DK1802573T3 (en) | 2016-12-19 |
US7923459B2 (en) | 2011-04-12 |
CN101056854B (zh) | 2013-06-05 |
HK1105195A1 (zh) | 2008-02-06 |
KR101319235B1 (ko) | 2013-10-16 |
CA2584831A1 (en) | 2006-04-20 |
WO2006040155A1 (en) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1802573T3 (pl) | Proces syntezy 4-(3-metanosulfonylofenylo)-1-N-propylopiperydyny | |
HK1199254A1 (en) | Process for the preparation of aurora kinase inhibitors | |
ZA200705130B (en) | Process for the synthesis of azetidinones | |
PL1761510T3 (pl) | Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn | |
IL192242A0 (en) | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides | |
ZA200700685B (en) | Novel piperidine derivative for the treatment of depression | |
IL192241A0 (en) | Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof | |
GB0623764D0 (en) | Process for the synthesis of hydromorphone | |
IL183528A0 (en) | Process for preparing rosuvastatin | |
IL185419A0 (en) | Improved process for the synthesis of enantiomeric indanylamine derivatives | |
PL1807395T3 (pl) | Sposób syntezy n-alkoksyamin | |
HK1099298A1 (en) | Improved process for preparing rebamipide | |
HUP0500537A3 (en) | Process for the preparation of rosuvastatin via new intermediates | |
HK1105968A1 (en) | Process for production of 3-alkenylcephem compounds 3- | |
IL180345A0 (en) | Improved process for the manufacture of mirtazapine | |
HU0402017D0 (en) | Environment-friend process for the synthesis of quaternary ammonio-steroids | |
PL378094A1 (pl) | Sposób wytwarzania aldehydów | |
HK1106783A1 (en) | Process for producing polyoxymethylene | |
GB0505861D0 (en) | Methods for the synthesis of heteroaromatic compounds | |
EG24122A (en) | Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines | |
IL181075A0 (en) | Process for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine | |
IL178960A0 (en) | Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds | |
HK1128287A1 (en) | Process for the preparation of tryptase inhibitors | |
HUP0401379A3 (en) | Process for the preparation of risperidon | |
IL191547A0 (en) | New process for the preparation of esomeprazole non-salt form |